Back to today’s briefing

Story perspectives

Hims & Hers Sales Surge, Stock Plummets Despite Profit Beat

8/5/2025

38 4

Summary

Story summary

Hims & Hers Health achieved Q2 sales of $544.8 million, a 73% increase, but fell short of the $552 million forecast.
Adjusted profit reached 19 cents per share, surpassing the expected 15 cents.
The company upheld its annual sales guidance of $2.3 to $2.4 billion.
Following the earnings report, Hims stock dropped over 11% in after-hours trading.
CEO Andrew Dudum highlighted the commitment to personalized healthcare.

1 of 1

Story summary

Hims & Hers Health achieved Q2 sales of $544.8 million, a 73% increase, but fell short of the $552 million forecast.
Adjusted profit reached 19 cents per share, surpassing the expected 15 cents.
The company upheld its annual sales guidance of $2.3 to $2.4 billion.
Following the earnings report, Hims stock dropped over 11% in after-hours trading.
CEO Andrew Dudum highlighted the commitment to personalized healthcare.